| abstract |
(57) [Summary] [Structure] General formula: [Wherein R 1 is an aryl group or heterocyclic group which may have a suitable substituent, R 2 is an aryl group or heterocyclic group which may have a suitable substituent, and Y is 2] And [Chemical 3] And a pharmaceutically acceptable salt thereof. [Effect] This compound is a potent interleukin 1 (I Since it has an L-1) production inhibitory action, it is useful as a preventive and therapeutic drug for IL-1 mediated diseases. |